The revised EBM catalog for the second quarter of 2026 published in Germany

On April 1, 2026, the revised EBM (German Uniform Evaluation Standard) catalog for the second quarter of 2026 came into force. The EBM catalog is used to reimburse day case and outpatient services under the fee-for-service model.

The main changes introduced concern updates of the contents (service legends, preambles of several EBM subchapters) and the introduction of new EBM codes for the reimbursement of lung cancer screening, monitoring progress and evaluating the digital health application (DiGA) Kranus Mictera, as well as several IVD tests.

The examples of the codes introduced are provided below:

EBM sub-chapter 1.7.2 “Early detection of diseases in adults”

• Code 01871 “Low-dose computed tomography for the early detection of lung cancer in line with section D. III. of the Cancer Screening Directive” with a tariff of €95.04.

EBM sub-chapter 1.4 “Visits, rounds, assessment of home nursing care, prescription of special treatment measures, administrative complex, telephone consultation, consultation fee, extended stay, counseling on organ and tissue donation”

• Code 01482 “Additional fee for monitoring progress and evaluating the digital health application (DiGA) Kranus Mictera in line with the Directory of digital health applications according to §139e SGB V” with a tariff of €8.15.

EBM sub-chapter 11.4.5 “In vitro diagnostics of hereditary alterations for the indication of pharmacological therapy”

• Code 11602 “Determination of the ApoE genotype prior to administration of lecanemab in confirmed early Alzheimer's disease with proven amyloid-beta pathology according to the summary of product characteristics (SmPC)” with a tariff of €53.76.

The full details in German can be found here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.